Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Proffered paper session - Public health policy

2774 - Relation between center volumes for pancreatic and esophageal cancer surgeries and outcome in Belgium: a plea for centralization


22 Oct 2018


Proffered paper session - Public health policy


Bioethical Principles and GCP;  Surgical Oncology

Tumour Site

Oesophageal Cancer;  Pancreatic Adenocarcinoma


Liesbet Van Eycken


Annals of Oncology (2018) 29 (suppl_8): viii562-viii575. 10.1093/annonc/mdy297


H. De Schutter1, G. Silversmit1, K. Haustermans2

Author affiliations

  • 1 Research Department, Belgian Cancer Registry, 1210 - Brussels/BE
  • 2 Department Of Radiation oncology, University Hospitals Leuven, 3000 - Leuven/BE


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 2774


Known for its accessible health care, Belgium currently counts over 100 hospitals providing oncological care, resulting in shattered care which may negatively influence outcomes. In the context of recent centralization initiatives, this study aimed to evaluate relations between complex surgeries and outcomes for (peri)pancreatic and esophageal cancers at the Belgian population level.


All patients with (peri)pancreatic (ICD)10: C25, C17.0, C24.0-1) or esophageal (C15-C16.0) cancer between 2007 and 2014 were extracted from the Belgian Cancer Registry and linked with surgeries (Sx) from reimbursement data. Concordant with previous reports, three yearly volume categories of Sx per center were defined ((peri)pancreatic: <6, 6-14 and ≥15 Sx/yr; esophageal: <6, 6-19 and ≥20 Sx/yr). Relations between surgical volumes and 30-days postoperative mortality as well as 5-year overall survival (OS) were analyzed with multivariable regression models adjusting for case-mix (including age, stage, sex, comorbidities).


16,471 (peri)pancreatic and 12,241 esophageal cancers were retrieved, corresponding to 4,081 (peri)pancreatic and 3,387 esophageal cancer surgeries performed by 96 hospitals in total (in 2014: 68 hospitals for (peri)pancreatic and 54 for esophageal cancer Sx). Surgical volumes were significantly related with 30-days postoperative mortality for (peri)pancreatic and esophageal cancer (p = 0.005 and p < 0.0001 respectively), with 52% and 81% mortality reduction for high vs low volume hospitals, respectively. The volume effect was also seen for OS: for both cancer types, high volume hospitals had a better OS compared to low volume which remained significant after case mix adjustment. For (peri)pancreatic cancer, 1-yr and 5-yr OS for high versus low volume centers was 75% vs 69% and 34% vs 31%, respectively (HR 0.65 [0.55, 0.78], p < 0.0001). For esophageal cancer, 1-yr and 5-yr OS for high versus low volume centers was 79% vs 71% and 44% vs 38%, respectively (HR 0.88 [0.79;0.99], p = 0.04).


High surgical volume centers showed better results for postoperative mortality and survival for (peri)pancreatic and esophageal cancers, supporting centralization initiatives in Belgium.

Clinical trial identification

Legal entity responsible for the study

Foundation Belgian Cancer Registry.


Federal and Regional Authorities.

Editorial Acknowledgement


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.